 |
PDBsum entry 1uw3
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Membrane protein
|
PDB id
|
|
|
|
1uw3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
336:1175-1183
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
The crystal structure of the globular domain of sheep prion protein.
|
|
L.F.Haire,
S.M.Whyte,
N.Vasisht,
A.C.Gill,
C.Verma,
E.J.Dodson,
G.G.Dodson,
P.M.Bayley.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The prion protein PrP is a naturally occurring polypeptide that becomes
transformed from a normal conformation to that of an aggregated form,
characteristic of pathological states in fatal transmissible spongiform
conditions such as Creutzfeld-Jacob Disease and Bovine Spongiform
Encephalopathy. We report the crystal structure, at 2 A resolution, of residues
123-230 of the C-terminal globular domain of the ARQ allele of sheep prion
protein (PrP). The asymmetric unit contains a single molecule whose secondary
structure and overall organisation correspond to those structures of PrPs from
various mammalian species determined by NMR. The globular domain shows a close
association of helix-1, the C-terminal portion of helix-2 and the N-terminal
portion of helix-3, bounded by the intramolecular disulphide bond, 179-214. The
loop 164-177, between beta2 and helix-2 is relatively well structured compared
to the human PrP NMR structure. Analysis of the sheep PrP structure identifies
two possible loci for the initiation of beta-sheet mediated polymerisation. One
of these comprises the beta-strand, residues 129-131 that forms an
intra-molecular beta-sheet with residues 161-163. This strand is involved in
lattice contacts about a crystal dyad to generate a four-stranded intermolecular
beta-sheet between neighbouring molecules. The second locus involves the region
188-204, which modelling suggests is able to undergo a partial alpha-->beta
switch within the monomer. These loci provide sites within the PrPc monomer that
could readily give rise to early intermediate species on the pathway to the
formation of aggregated PrPSc containing additional intermolecular
beta-structure.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. A, Portion of a CNS all omit map covering the
vicinity of the phosphate ion linking the segment of the
polypeptide at the immediate N terminus of helix-1 with the
middle section of helix-3. (Liganding to Glu146 is not shown for
clarity, see the text.) B, Schematic representation of the sheep
PrP molecule. The helices, labelled H1-H3, are shown in blue,
and the short segments of anti-parallel b-sheet are shown in
red. C, Schematic representation of the helix-swapped dimer
structure of the human prion protein.[6.] The bottom half of the
dimer is in the same orientation as the sheep PrP shown in B and
similarly coloured, but with H3 in light blue. The dyad-related
monomer is at the top and its b-strands are coloured in green.
The helices for the dyad-related molecule are distinguished by a
prime. The exchange of H3 and H3' is accompanied by the
formation of an additional segment of anti-parallel b-sheet,
coloured in red and green (Figure drawn with Spock).
|
 |
Figure 3.
Figure 3. Comparison of the crystal structure of the
globular domain of the ARQ allele of sheep PrP (blue) and the
NMR structure of human PrP (yellow: 1hjm.pdb): least-squares
superimposition of common residues, with an rms DIFFERENCE=1.73
Å for 100 C^a atoms. In addition to the three helices, the
intramolecular b-sheet (arrows, b1:129-131; b2:161-163) is shown
in red for sheep PrP, and grey for human PrP. The YYR epitope is
at 162-164. The loop 164-174 between b2 and H2, is shown in
green for sheep PrP. The three polymorphic residues of sheep
(A133,R151,Q168), are shown in magenta (Figure drawn with Spock).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2004,
336,
1175-1183)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.A.Tabrett,
C.F.Harrison,
B.Schmidt,
S.A.Bellingham,
T.Hardy,
Y.H.Sanejouand,
A.F.Hill,
and
P.J.Hogg
(2010).
Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function.
|
| |
Biochem J,
428,
169-182.
|
 |
|
|
|
|
 |
M.I.Apostol,
M.R.Sawaya,
D.Cascio,
and
D.Eisenberg
(2010).
Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease.
|
| |
J Biol Chem,
285,
29671-29675.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Q.Khan,
B.Sweeting,
V.K.Mulligan,
P.E.Arslan,
N.R.Cashman,
E.F.Pai,
and
A.Chakrabartty
(2010).
Prion disease susceptibility is affected by beta-structure folding propensity and local side-chain interactions in PrP.
|
| |
Proc Natl Acad Sci U S A,
107,
19808-19813.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Lee,
L.Antony,
R.Hartmann,
K.J.Knaus,
K.Surewicz,
W.K.Surewicz,
and
V.C.Yee
(2010).
Conformational diversity in prion protein variants influences intermolecular beta-sheet formation.
|
| |
EMBO J,
29,
251-262.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Nazabal,
S.Hornemann,
A.Aguzzi,
and
R.Zenobi
(2009).
Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
|
| |
J Mass Spectrom,
44,
965-977.
|
 |
|
|
|
|
 |
E.D.Walter,
D.J.Stevens,
A.R.Spevacek,
M.P.Visconte,
A.Dei Rossi,
and
G.L.Millhauser
(2009).
Copper binding extrinsic to the octarepeat region in the prion protein.
|
| |
Curr Protein Pept Sci,
10,
529-535.
|
 |
|
|
|
|
 |
F.Cui,
K.Mukhopadhyay,
W.B.Young,
R.L.Jernigan,
and
Z.Wu
(2009).
Refinement of under-determined loops of Human Prion Protein by database-derived distance constraints.
|
| |
Int J Data Min Bioinform,
3,
454-468.
|
 |
|
|
|
|
 |
L.Ronga,
P.Palladino,
R.Ragone,
E.Benedetti,
and
F.Rossi
(2009).
A thermodynamic approach to the conformational preferences of the 180-195 segment derived from the human prion protein alpha2-helix.
|
| |
J Pept Sci,
15,
30-35.
|
 |
|
|
|
|
 |
O.Polyakova,
D.Dear,
I.Stern,
S.Martin,
E.Hirst,
S.Bawumia,
A.Nash,
G.Dodson,
I.Bronstein,
and
P.M.Bayley
(2009).
Proteolysis of prion protein by cathepsin S generates a soluble beta-structured intermediate oligomeric form, with potential implications for neurotoxic mechanisms.
|
| |
Eur Biophys J,
38,
209-218.
|
 |
|
|
|
|
 |
R.A.Moore,
L.M.Taubner,
and
S.A.Priola
(2009).
Prion protein misfolding and disease.
|
| |
Curr Opin Struct Biol,
19,
14-22.
|
 |
|
|
|
|
 |
S.V.Antonyuk,
C.R.Trevitt,
R.W.Strange,
G.S.Jackson,
D.Sangar,
M.Batchelor,
S.Cooper,
C.Fraser,
S.Jones,
T.Georgiou,
A.Khalili-Shirazi,
A.R.Clarke,
S.S.Hasnain,
and
J.Collinge
(2009).
Crystal structure of human prion protein bound to a therapeutic antibody.
|
| |
Proc Natl Acad Sci U S A,
106,
2554-2558.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Ronga,
P.Palladino,
G.Saviano,
T.Tancredi,
E.Benedetti,
R.Ragone,
and
F.Rossi
(2008).
Structural characterization of a neurotoxic threonine-rich peptide corresponding to the human prion protein alpha 2-helical 180-195 segment, and comparison with full-length alpha 2-helix-derived peptides.
|
| |
J Pept Sci,
14,
1096-1102.
|
 |
|
|
|
|
 |
M.C.Colombo,
J.Vandevondele,
S.Van Doorslaer,
A.Laio,
L.Guidoni,
and
U.Rothlisberger
(2008).
Copper binding sites in the C-terminal domain of mouse prion protein: A hybrid (QM/MM) molecular dynamics study.
|
| |
Proteins,
70,
1084-1098.
|
 |
|
|
|
|
 |
S.Noinville,
J.F.Chich,
and
H.Rezaei
(2008).
Misfolding of the prion protein: linking biophysical and biological approaches.
|
| |
Vet Res,
39,
48.
|
 |
|
|
|
|
 |
V.Gayrard,
N.Picard-Hagen,
C.Viguié,
E.Jeunesse,
G.Tabouret,
H.Rezaei,
and
P.L.Toutain
(2008).
Blood clearance of the prion protein introduced by intravenous route in sheep is influenced by host genetic and physiopathologic factors.
|
| |
Transfusion,
48,
609-619.
|
 |
|
|
|
|
 |
A.De Simone,
A.Zagari,
and
P.Derreumaux
(2007).
Structural and hydration properties of the partially unfolded states of the prion protein.
|
| |
Biophys J,
93,
1284-1292.
|
 |
|
|
|
|
 |
A.Pastore,
and
A.Zagari
(2007).
A structural overview of the vertebrate prion proteins.
|
| |
Prion,
1,
185-197.
|
 |
|
|
|
|
 |
C.W.Lennon,
H.D.Cox,
S.P.Hennelly,
S.J.Chelmo,
and
M.A.McGuirl
(2007).
Probing structural differences in prion protein isoforms by tyrosine nitration.
|
| |
Biochemistry,
46,
4850-4860.
|
 |
|
|
|
|
 |
G.L.Millhauser
(2007).
Copper and the prion protein: methods, structures, function, and disease.
|
| |
Annu Rev Phys Chem,
58,
299-320.
|
 |
|
|
|
|
 |
I.V.Baskakov
(2007).
The reconstitution of mammalian prion infectivity de novo.
|
| |
FEBS J,
274,
576-587.
|
 |
|
|
|
|
 |
L.Ronga,
E.Langella,
P.Palladino,
D.Marasco,
B.Tizzano,
M.Saviano,
C.Pedone,
R.Improta,
and
M.Ruvo
(2007).
Does tetracycline bind helix 2 of prion? An integrated spectroscopical and computational study of the interaction between the antibiotic and alpha helix 2 human prion protein fragments.
|
| |
Proteins,
66,
707-715.
|
 |
|
|
|
|
 |
Y.Sun,
L.Breydo,
N.Makarava,
Q.Yang,
O.V.Bocharova,
and
I.V.Baskakov
(2007).
Site-specific conformational studies of prion protein (PrP) amyloid fibrils revealed two cooperative folding domains within amyloid structure.
|
| |
J Biol Chem,
282,
9090-9097.
|
 |
|
|
|
|
 |
C.D.Wu,
W.Y.Pang,
and
D.M.Zhao
(2006).
Comparative analysis of the prion protein gene sequences in African lion.
|
| |
Virus Genes,
33,
213-214.
|
 |
|
|
|
|
 |
E.Langella,
R.Improta,
O.Crescenzi,
and
V.Barone
(2006).
Assessing the acid-base and conformational properties of histidine residues in human prion protein (125-228) by means of pK(a) calculations and molecular dynamics simulations.
|
| |
Proteins,
64,
167-177.
|
 |
|
|
|
|
 |
L.Ronga,
B.Tizzano,
P.Palladino,
R.Ragone,
E.Urso,
M.Maffia,
M.Ruvo,
E.Benedetti,
and
F.Rossi
(2006).
The prion protein: Structural features and related toxic peptides.
|
| |
Chem Biol Drug Des,
68,
139-147.
|
 |
|
|
|
|
 |
L.Ronga,
P.Palladino,
B.Tizzano,
D.Marasco,
E.Benedetti,
R.Ragone,
and
F.Rossi
(2006).
Effect of salts on the structural behavior of hPrP alpha2-helix-derived analogues: the counterion perspective.
|
| |
J Pept Sci,
12,
790-795.
|
 |
|
|
|
|
 |
M.R.Hicks,
A.C.Gill,
I.K.Bath,
A.K.Rullay,
I.D.Sylvester,
D.H.Crout,
and
T.J.Pinheiro
(2006).
Synthesis and structural characterization of a mimetic membrane-anchored prion protein.
|
| |
FEBS J,
273,
1285-1299.
|
 |
|
|
|
|
 |
S.Petrakis,
and
T.Sklaviadis
(2006).
Identification of proteins with high affinity for refolded and native PrPC.
|
| |
Proteomics,
6,
6476-6484.
|
 |
|
|
|
|
 |
A.De Simone,
G.G.Dodson,
C.S.Verma,
A.Zagari,
and
F.Fraternali
(2005).
Prion and water: tight and dynamical hydration sites have a key role in structural stability.
|
| |
Proc Natl Acad Sci U S A,
102,
7535-7540.
|
 |
|
|
|
|
 |
B.Tizzano,
P.Palladino,
A.De Capua,
D.Marasco,
F.Rossi,
E.Benedetti,
C.Pedone,
R.Ragone,
and
M.Ruvo
(2005).
The human prion protein alpha2 helix: a thermodynamic study of its conformational preferences.
|
| |
Proteins,
59,
72-79.
|
 |
|
|
|
|
 |
D.A.Lysek,
C.Schorn,
L.G.Nivon,
V.Esteve-Moya,
B.Christen,
L.Calzolai,
C.von Schroetter,
F.Fiorito,
T.Herrmann,
P.Güntert,
and
K.Wüthrich
(2005).
Prion protein NMR structures of cats, dogs, pigs, and sheep.
|
| |
Proc Natl Acad Sci U S A,
102,
640-645.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Calzolai,
D.A.Lysek,
D.R.Pérez,
P.Güntert,
and
K.Wüthrich
(2005).
Prion protein NMR structures of chickens, turtles, and frogs.
|
| |
Proc Natl Acad Sci U S A,
102,
651-655.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Redecke,
W.Meyer-Klaucke,
M.Koker,
J.Clos,
D.Georgieva,
N.Genov,
H.Echner,
H.Kalbacher,
M.Perbandt,
R.Bredehorst,
W.Voelter,
and
C.Betzel
(2005).
Comparative analysis of the human and chicken prion protein copper binding regions at pH 6.5.
|
| |
J Biol Chem,
280,
13987-13992.
|
 |
|
|
|
|
 |
O.V.Bocharova,
L.Breydo,
V.V.Salnikov,
A.C.Gill,
and
I.V.Baskakov
(2005).
Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease.
|
| |
Protein Sci,
14,
1222-1232.
|
 |
|
|
|
|
 |
R.Bujdoso,
D.F.Burke,
and
A.M.Thackray
(2005).
Structural differences between allelic variants of the ovine prion protein revealed by molecular dynamics simulations.
|
| |
Proteins,
61,
840-849.
|
 |
|
|
|
|
 |
E.Langella,
R.Improta,
and
V.Barone
(2004).
Checking the pH-induced conformational transition of prion protein by molecular dynamics simulations: effect of protonation of histidine residues.
|
| |
Biophys J,
87,
3623-3632.
|
 |
|
|
|
|
 |
F.Eghiaian,
J.Grosclaude,
S.Lesceu,
P.Debey,
B.Doublet,
E.Tréguer,
H.Rezaei,
and
M.Knossow
(2004).
Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
|
| |
Proc Natl Acad Sci U S A,
101,
10254-10259.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.L.Hosszu,
G.S.Jackson,
C.R.Trevitt,
S.Jones,
M.Batchelor,
D.Bhelt,
K.Prodromidou,
A.R.Clarke,
J.P.Waltho,
and
J.Collinge
(2004).
The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC.
|
| |
J Biol Chem,
279,
28515-28521.
|
 |
|
|
|
|
 |
R.I.Dima,
and
D.Thirumalai
(2004).
Probing the instabilities in the dynamics of helical fragments from mouse PrPC.
|
| |
Proc Natl Acad Sci U S A,
101,
15335-15340.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |